ANGLE plc (LON:AGL – Get Free Report) dropped 3.4% on Monday . The stock traded as low as GBX 2.73 ($0.04) and last traded at GBX 2.80 ($0.04). Approximately 999,491 shares changed hands during trading, a decline of 27% from the average daily volume of 1,363,741 shares. The stock had previously closed at GBX 2.90 ($0.04).
ANGLE Stock Down 3.4%
The company has a market capitalization of £9.03 million, a P/E ratio of -58.09 and a beta of 0.22. The company has a 50 day simple moving average of GBX 5.35 and a two-hundred day simple moving average of GBX 7.15. The company has a quick ratio of 6.18, a current ratio of 5.19 and a debt-to-equity ratio of 17.22.
ANGLE (LON:AGL – Get Free Report) last announced its quarterly earnings results on Tuesday, September 9th. The company reported GBX (2.87) earnings per share for the quarter. ANGLE had a negative net margin of 890.91% and a negative return on equity of 76.01%. As a group, equities analysts predict that ANGLE plc will post -8.6599997 EPS for the current year.
About ANGLE
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.
See Also
- Five stocks we like better than ANGLE
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- 3 Emerging Stocks You Haven’t Heard Much From This Cycle
- What is a Secondary Public Offering? What Investors Need to Know
- Costco Investors Will Get A “Special” Treat For Christmas
- What is the Euro STOXX 50 Index?
- 3 Ways to Test the Crypto Market Without Owning Bitcoin
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.
